Eton Pharmaceuticals, Inc. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/760dacc4-5970-47de-b990-e5366eb8ead4/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $80.0M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-009059 |
| FY 2024 | $39.0M | 2024-01-01 – 2024-12-31 | evidence 0001437749-25-008136 |
| FY 2023 | $31.6M | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-007853 |
| FY 2022 | $21.3M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-007933 |
| FY 2021 | $21.8M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-006990 |
| FY 2020 | $39.0k | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-006122 |
| FY 2019 | $959.0k | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-003451 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Eton Pharmaceuticals, Inc. — all facts · Net Income · Operating Income